Glaucoma Therapeutics Market
Glaucoma Therapeutics Market Report By Drug Class (Prostaglandins, Beta Blockers, Alpha Agonists, Carbonic, Anhydrase Inhibitors, Combination Medications, Cholinergic Medications), By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers) - Regional Forecast 2021 to 2031
Analysis of Glaucoma Therapeutics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT4775MR
- 22 Nov 2021
- Healthcare
- 170 Pages
- 56 Tables
- 56 Figures
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Market Outlook
- 6. Global Market Analysis and Forecasts, by Drug Class
- 6.1. Prostaglandins
- 6.2. Beta Blockers
- 6.3. Alpha Agonists
- 6.4. Carbonic Anhydrase Inhibitors
- 6.5. Combination Medications
- 6.6. Cholinergics
- 7. Global Market Analysis and Forecasts, by End-user
- 7.1. Hospitals
- 7.2. Ophthalmic Clinics
- 7.3. Ambulatory Surgical Centers
- 8. Global Market Analysis and Forecasts, by Region
- 8.1. North America
- 8.2. Europe
- 8.3. Asia Pacific
- 8.4. Latin America
- 8.5. Middle East & Africa
- 9. North America Market Analysis and Forecast
- 10. Europe Market Analysis and Forecast
- 11. Asia Pacific Market Analysis and Forecast
- 12. Latin America Market Analysis and Forecast
- 13. Middle East & Africa Market Analysis and Forecast
- 14. Competition Landscape
- 14.1. Allergan plc
- 14.2. Merck & Co., Inc.
- 14.3. Novartis AG
- 14.4. Pfizer Inc.
- 14.5. Santen Pharmaceuticals Co. Ltd.
- 14.6. Valeant Pharmaceuticals International, Inc.
- 14.7. Aerie Pharmaceuticals Inc.
List Of Table
Table 01: Global Market Size (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 02: Global Market Size (US$ Mn) Forecast, by End-user, 2021 to 2031
Table 03: Global Market Size (US$ Mn) Forecast, by Region, 2021 to 2031
Table 04: North America Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 05: North America Market Forecast, by End-user, 2021 to 2031
Table 06: North America Market Value (US$ Mn) Forecast, by Country, 2021 to 2031
Table 07: U.S. Market Forecast, by Drug Class, 2021 to 2031
Table 08: U.S. Market Forecast, by End-user, 2021 to 2031
Table 09: Canada Market Forecast, by Drug Class, 2021 to 2031
Table 10: Canada Market Forecast, by End-user, 2021 to 2031
Table 11: Europe Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 12: Europe Market Forecast, by End-user, 2021 to 2031
Table 13: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 14: U.K. Market Forecast, by Drug Class, 2021 to 2031
Table 15: U.K. Market Forecast, by End-user, 2021 to 2031
Table 16: Germany Market Forecast, by Drug Class, 2021 to 2031
Table 17: Germany Market Forecast, by End-user, 2021 to 2031
Table 18: France Market Forecast, by Drug Class, 2021 to 2031
Table 19: France Market Forecast, by End-user, 2021 to 2031
Table 20: Spain Market Forecast, by Drug Class, 2021 to 2031
Table 21: Spain Market Forecast, by End-user, 2021 to 2031
Table 22: Italy Market Forecast, by Drug Class, 2021 to 2031
Table 23: Italy Market Forecast, by End-user, 2021 to 2031
Table 24: Rest of Europe Market Forecast, by Drug Class, 2021 to 2031
Table 25: Rest of Europe Market Forecast, by End-user, 2021 to 2031
Table 26: Asia Pacific Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 27: Asia Pacific Market Forecast, by End-user, 2021 to 2031
Table 28: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 29: Japan Market Forecast, by Drug Class, 2021 to 2031
Table 30: Japan Market Forecast, by End-user, 2021 to 2031
Table 31: China Market Forecast, by Drug Class, 2021 to 2031
Table 32: China Market Forecast, by End-user, 2021 to 2031
Table 33: India Market Forecast, by Drug Class, 2021 to 2031
Table 34: India Market Forecast, by End-user, 2021 to 2031
Table 35: Australia & New Zealand Market Forecast, by Drug Class, 2021 to 2031
Table 36: Australia & New Zealand Market Forecast, by End-user, 2021 to 2031
Table 37: Rest of APAC Market Forecast, by Drug Class, 2021 to 2031
Table 38: Rest of APAC Market Forecast, by End-user, 2021 to 2031
Table 39: Latin America Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 40: Latin America Market Forecast, by End-user, 2021 to 2031
Table 41: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 42: Brazil Market Forecast, by Drug Class, 2021 to 2031
Table 43: Brazil Market Forecast, by End-user, 2021 to 2031
Table 44: Mexico Market Forecast, by Drug Class, 2021 to 2031
Table 45: Mexico Market Forecast, by End-user, 2021 to 2031
Table 46: Rest of LATAM Market Forecast, by Drug Class, 2021 to 2031
Table 47: Rest of LATAM Market Forecast, by End-user, 2021 to 2031
Table 48: Middle East & Africa Market Value (US$ Mn) Forecast, by Drug Class, 2021 to 2031
Table 49: Middle East & Africa Market Forecast, by End-user, 2021 to 2031
Table 50: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2021 to 2031
Table 51: GCC Countries Market Forecast, by Drug Class, 2021 to 2031
Table 52: GCC Countries Market Forecast, by End-user, 2021 to 2031
Table 53: South Africa Market Forecast, by Drug Class, 2021 to 2031
Table 54: South Africa Market Forecast, by End-user, 2021 to 2031
Table 55: Rest of MEA Market Forecast, by Drug Class, 2021 to 2031
Table 56: Rest of MEA Market Forecast, by End-user, 2021 to 2031
List Of Figures
Figure 01: Global Market Snapshot
Figure 02: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2021 to 2031
Figure 03: Market Value Share, by Drug Class (2020)
Figure 04: Market Value Share, by End-user (2020)
Figure 05: Market Value Share, by Region (2020)
Figure 06: Global Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 07: Global Prostaglandins Market Revenue (US$ Mn), 2021 to 2031
Figure 08: Global Beta Blockers Market Revenue (US$ Mn), 2021 to 2031
Figure 09: Global Alpha Agonist Market, Revenue (US$ Mn), 2021 to 2031
Figure 10: Global Carbonic Anhydrase Inhibitor (CAI) Market, Revenue (US$ Mn), 2021 to 2031
Figure 11: Global Combination Medications Market, Revenue (US$ Mn), 2021 to 2031
Figure 12: Global Cholinergic Market, Revenue (US$ Mn), 2021 to 2031
Figure 13: Global Market Attractiveness Analysis, by Drug Class
Figure 14: Global Market Value Share Analysis, by End-user, 2021 and 2031
Figure 15: Global Hospitals Market Revenue (US$ Mn), 2021 to 2031
Figure 16: Global Ophthalmic Clinics Market Revenue (US$ Mn), 2021 to 2031
Figure 17: Global Ambulatory Surgical Centers Market Revenue (US$ Mn), 2021 to 2031
Figure 18: Global Market Attractiveness Analysis, by End-user
Figure 19: Global Market Value Share Analysis, by Region, 2021 and 2031
Figure 20: Global Market Attractiveness Analysis, by Region, 2020 to 2031
Figure 21: North America Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 22: North America Market Attractiveness Analysis, by Country
Figure 23: North America Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 24: North America Market Value Share Analysis, by End-user, 2021 and 2031
Figure 25: North America Market, by Country, 2021 and 2031
Figure 26: North America Market Attractiveness Analysis, by Drug Class
Figure 27: North America Market Attractiveness Analysis, by End-user
Figure 28: Europe Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 29: Europe Market Attractiveness Analysis, by Country/Sub-Region
Figure 30: Europe Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 31: Europe Market Value Share Analysis, by End-user, 2021 and 2031
Figure 32: Europe Market, by Country/Sub-region
Figure 33: Europe Market Attractiveness Analysis, by Drug Class
Figure 34: Europe Market Attractiveness Analysis, by End-user
Figure 35: Asia Pacific Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 36: Asia Pacific Market Attractiveness Analysis, by Country/Sub-Region
Figure 37: Asia Pacific Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 38: Asia Pacific Market Value Share Analysis, by End-user, 2021 and 2031
Figure 39: Asia Pacific Market, by Country/Sub-region
Figure 40: Asia Pacific Market Attractiveness Analysis, by Drug Class
Figure 41: Asia Pacific Market Attractiveness Analysis, by End-user
Figure 42: Latin America Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 43: Latin America Market Attractiveness Analysis, by Country/Sub-region
Figure 44: Latin America Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 45: Latin America Market Value Share Analysis, by End-user, 2021 and 2031
Figure 46: North America Market, by Country/Sub-region
Figure 47: Latin America Market Attractiveness Analysis, by Drug Class
Figure 48: Latin America Market Attractiveness Analysis, by End-user
Figure 49: Middle East & Africa Market Value (US$ Mn) Forecast, 2021 to 2031
Figure 50: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
Figure 51: Middle East & Africa Market Value Share Analysis, by Drug Class, 2021 and 2031
Figure 52: Middle East & Africa Market Value Share Analysis, by End-user, 2021 and 2031
Figure 53: Middle East & Africa Market, by Country/Sub-region
Figure 54: Middle East & Africa Market Attractiveness Analysis, by Drug Class
Figure 55: Middle East & Africa Market Attractiveness Analysis, by End-user
Figure 56: Global Market Share Analysis, by Company (2020)
Glaucoma Therapeutics Market